Business Description
Aadi Bioscience Inc
NAICS : 325412
SIC : 2834
ISIN : US00032Q1040
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 85.91 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -2.42 | |||||
Beneish M-Score | -1.34 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.4 | |||||
3-Year EBITDA Growth Rate | -167.4 | |||||
3-Year EPS without NRI Growth Rate | -144.5 | |||||
3-Year FCF Growth Rate | -57.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 15.77 | |||||
9-Day RSI | 24.41 | |||||
14-Day RSI | 33.39 | |||||
6-1 Month Momentum % | -46.87 | |||||
12-1 Month Momentum % | -74.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.72 | |||||
Quick Ratio | 4.48 | |||||
Cash Ratio | 4.12 | |||||
Days Inventory | 498.01 | |||||
Days Sales Outstanding | 66.87 | |||||
Days Payable | 556.92 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | 0.04 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 88.47 | |||||
Operating Margin % | -295.36 | |||||
Net Margin % | -270.04 | |||||
FCF Margin % | -261.29 | |||||
ROE % | -49.88 | |||||
ROA % | -42.25 | |||||
ROIC % | -1092.64 | |||||
ROC (Joel Greenblatt) % | -1569.45 | |||||
ROCE % | -48.07 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.04 | |||||
PB Ratio | 0.43 | |||||
Price-to-Tangible-Book | 0.43 | |||||
EV-to-EBIT | 0.97 | |||||
EV-to-EBITDA | 0.97 | |||||
EV-to-Revenue | -2.6 | |||||
EV-to-Forward-Revenue | 0.49 | |||||
EV-to-FCF | 0.99 | |||||
Price-to-Net-Current-Asset-Value | 0.46 | |||||
Price-to-Net-Cash | 0.55 | |||||
Earnings Yield (Greenblatt) % | 103.09 | |||||
FCF Yield % | -142 |